Joe Aoun
Interventional Cardiology · Houston, TXNPI 1023460276
Payments from drug & device makers
Across 360 payments — averaging $439.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$139K
- Medtronic$6K
- Abbott$6K
- Boston Scientific$1K
- Abiomed$1K
- Edwards Lifesciences$800
- plus $3K from 22 others
What the payments were for
- Travel & lodging$4,95526%
- Food & beverage$13,69272%
- Education$3792%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 8 | $139,119 |
| Medtronic | 107 | $6,383 |
| Abbott | 92 | $6,239 |
| Boston Scientific | 13 | $1,226 |
| Abiomed | 15 | $1,021 |
| Edwards Lifesciences | 10 | $800 |
| Philips North America LLC | 6 | $608 |
| Amgen | 32 | $589 |
| Biosense Webster, Inc. | 26 | $547 |
| Cardiva Medical, Inc. | 4 | $307 |
| Pfizer | 13 | $216 |
| Astellas Pharma US Inc | 4 | $160 |
| Novartis | 8 | $148 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $135 |
| Heartflow, Inc. | 1 | $113 |
| Penumbra, Inc. | 1 | $88 |
| Merck | 1 | $78 |
| Chiesi USA, Inc. | 3 | $73 |
| Getinge USA Sales, LLC | 2 | $66 |
| Lemaitre Vascular, Inc. | 1 | $30 |
| Boehringer Ingelheim | 1 | $28 |
| Siemens Medical Solutions USA, Inc. | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$2,587
- MitraClip$1,327
- RESOLUTE ONYX$1,160
- OPTIS$891
- Impella$548
- DRAGONFLY OPSTAR$346
- Resolute$280
- SAPIEN 3 Ultra RESILIA$271
- (9520) IGT Devices Undivided$263
- TRICLIP$259
- AVVIGO Guidance System$232
- CoreValve Evolut$146
- WATCHMAN FLX$136
- ESPRIT$135
- SYNERGY$128
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$121
- FFRct$113
- (BQ9) Coronary IVUS$113
- ENSITE PRECISION$104
- (6342) Intrasight Integrated$104
How this compares
$158,090 in reported general payments places this provider in the 85th percentile of 686 interventional cardiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 60 | $671 |
| Atorvastatin Calcium | 19 | $349 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Houston
- Neal KleimanHouston$4.8M
- Juan GranadaHouston$4.3M
- Abhijeet DhobleHouston$2.7M
- John IsaacHouston$1.8M
- Amir KashaniHouston$1.3M
- Biswajit KarHouston$785K
- Michele SartoriHouston$603K
- Guilherme SilvaHouston$516K
- Sachin KumarHouston$446K
- Marwan JumeanHouston$427K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.